EXOPHARM LIMITED

EX1

equity

AUD $0.070

0.001 (1.45%)

Updated: 20 Jan, 1:54 am UTC

Description

Exopharm Limited is a biopharmaceutical company focused on the development and commercialisation of innovative treatments for cancer, autoimmune and other diseases. The company is focused on advancing its lead product, EXO-CD24, a novel first-in-class cancer immunotherapy, through clinical development and partnering activities. The company also undertakes research and development activities to identify and develop additional therapeutic candidates. Exopharm's mission is to develop and commercialise innovative medicines to improve the lives of patients living with cancer, autoimmune and other diseases.

Activity
Last price		$0.070
Change		0.001 (1.45%)
Bid/Ask		$0.067 - $0.070
Volume		53,396.00
Volume traded/total %		0.034%
Volume avg (4w)		132,960.00
Open		$0.069
Day range		$0.069 - $0.070
Previous Close		$0.069
Last Trade		20 Jan, 1:54 am UTC

Size
Market Cap		$10.85M
Market Rank		2282
Industry Rank		94

Fundamentals
Shares Issued		157.21M
Earnings Per Share (EPS)		$-0.064
Dividends Per Share (DPS)		-
P/E Ratio		-

Similar to